RecruitingNot ApplicableNCT04554212

Blood Flow Restriction Training After Patellar INStability

Blood Flow Restriction Training After Patellar INStability (BRAINS Trial)


Sponsor

Caitlin Conley

Enrollment

78 participants

Start Date

Sep 9, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called blood flow restriction training (called BFRT) will improve recovery for those with patellar instability.


Eligibility

Min Age: 14 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Blood Flow Restriction Training and a medical device called Sham Blood Flow Restriction Training for people with knee injuries, leg injury, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 14 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBlood Flow Restriction Training

Participants will undergo 8 weeks of blood flow restriction training with cuff inflated to 60% occlusion.

DEVICESham Blood Flow Restriction Training

Participants will undergo 8 weeks of sham blood flow restriction training with cuff inflated to less than 10% occlusion.


Locations(4)

UK Healthcare at Turfland

Lexington, Kentucky, United States

University of Kentucky Biomotion Laboratory

Lexington, Kentucky, United States

Center for Sports Performance and Research

Foxborough, Massachusetts, United States

Foxboro Sports Medicine Clinic

Foxborough, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04554212


Related Trials